Huons receives FDA approval for 2% lidocaine injection

Huons received FDA ANDA approval for its 2% lidocaine injection 5mL vial, a local anesthetic, and is expanding production lines at its Jecheon 2 plant with a 24.5 billion won investment to increase vial and cartridge capacity.

“휴온스는 미국 FDA로부터 2% 리도카인주사제 5mL 바이알에 대한 의약국 품목허가(ANDA) 승인을 획득했다.”thevaluenews.co.kr

• 1 source
• thevaluenews.co.kr휴온스, 국소마취제 ‘2% 리도카인’ FDA 승인… ”북미 시장 확대”Jun 19, 2023

Summarized from public sources; check the original articles before acting on it.